CN106942712A - 一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 - Google Patents
一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 Download PDFInfo
- Publication number
- CN106942712A CN106942712A CN201710152471.8A CN201710152471A CN106942712A CN 106942712 A CN106942712 A CN 106942712A CN 201710152471 A CN201710152471 A CN 201710152471A CN 106942712 A CN106942712 A CN 106942712A
- Authority
- CN
- China
- Prior art keywords
- parts
- chlorella
- ganoderma lucidum
- powder
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 55
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 53
- 241000195649 Chlorella <Chlorellales> Species 0.000 title claims abstract description 46
- 150000001875 compounds Chemical class 0.000 title claims abstract description 41
- 210000004369 blood Anatomy 0.000 title claims abstract description 34
- 239000008280 blood Substances 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 150000002632 lipids Chemical class 0.000 title claims abstract description 26
- 235000013305 food Nutrition 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 43
- 239000012141 concentrate Substances 0.000 claims abstract description 33
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 20
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 20
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 18
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 15
- 244000241872 Lycium chinense Species 0.000 claims abstract description 13
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 13
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000003809 water extraction Methods 0.000 claims abstract description 4
- 235000013402 health food Nutrition 0.000 claims abstract 2
- 238000001914 filtration Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims description 2
- 238000003801 milling Methods 0.000 claims description 2
- 230000035764 nutrition Effects 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- -1 electuary Substances 0.000 claims 1
- 235000009200 high fat diet Nutrition 0.000 abstract description 8
- 108010028554 LDL Cholesterol Proteins 0.000 abstract description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 5
- 238000002474 experimental method Methods 0.000 abstract description 3
- 210000002966 serum Anatomy 0.000 abstract description 3
- 230000006698 induction Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000037356 lipid metabolism Effects 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000003285 pharmacodynamic effect Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 230000036541 health Effects 0.000 description 21
- 230000000694 effects Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- 229960003438 aspartame Drugs 0.000 description 3
- 235000010357 aspartame Nutrition 0.000 description 3
- 239000000605 aspartame Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 241000208343 Panax Species 0.000 description 2
- 244000000231 Sesamum indicum Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000010977 jade Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000196319 Chlorophyceae Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法,主要原料按重量份数计包括:灵芝粉10‑30份,小球藻粉5‑10份,山药10‑20份,西洋参3‑6份,枸杞子10‑20份,绞股蓝10‑20份。将灵芝子实体原料磨粉后,经热水浸提减压浓缩后干燥,制备灵芝水提取物干粉,然后将小球藻,山药,西洋参,枸杞子,绞股蓝混料,经热水浸提、过滤、减压浓缩制备成复方浓缩液,以复方浓缩液和灵芝水提取物干粉为主料制备具有辅助降血脂的保健食品。经药效学实验验证,复方浓缩液和灵芝水提取物干粉复合物能够显著改善高脂饮食诱导的肥胖大鼠脂质代谢紊乱,能够显著降低血清中总胆固醇、甘油三脂以及低密度脂蛋白胆固醇的水平。
Description
技术领域
本发明属于保健食品技术领域,具体涉及一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法。
背景技术
随着生活水平的提高和生活节奏的改变,被称为“富贵病”的“三高症”发病率越来越高,特别是50岁以上中老年人健康的常见病,高血脂可以引起血管栓塞;高血压可以引起脑出血和脑血管破裂;高血糖可以引起糖尿病。全世界每年死于心脑血管疾病的人数高达1500万人,居各种死因首位。因此寻找开发具有降血脂血压的保健品,以辅助药物治疗,在有效的控制血糖和血脂的同时降低副作用已引起人们的关注。
灵芝又称林中灵、琼珍,是多孔菌科真菌灵芝的子实体。具有补气安神、止咳平喘、延年益寿。尤其是灵芝三萜等小分子活性物质的降血脂血压的功效非常显著。小球藻属绿藻纲,小球藻科,是一种优质的绿色营养源食品,具有高蛋白、低脂肪、低糖、低热量以及维生素、矿物质元素含量丰富的优点,并且具有降血脂降血压,抗氧化,解毒,抗肿瘤增强免疫力等保健功能。山药具有滋养强壮,助消化,敛虚汗,止泻之功效。其最适宜与灵芝搭配服用,具有防治糖尿病的作用。西洋参是五加科人参属多年生草木植物,别名花旗参、洋参等,其主要成分为人参皂苷,可以有效增强中枢神经,达到静心凝神、消除疲劳、增强记忆力等作用。常服西洋参可以抗心律失常、抗心肌缺血、抗心肌氧化、强化心肌收缩能力,养胃生津,降血脂等诸多功效。枸杞子富含枸杞多糖,枸杞多糖是一种水溶性多糖具有生理活性,能够增强免疫功能,提高抗病能力,抑制肿瘤生长和细胞突变,降血脂血压,美容养颜等一系列功效。绞股蓝又称天堂草,是葫芦科、绞股蓝属草质攀援植物。用绞股蓝与灵芝搭配煮水或泡茶喝,可治疗高血脂、高血糖,脂肪肝等症。且有保肝解毒、降血脂血糖的功效。
本发明以灵芝,小球藻,山药等为原料制备了一种灵芝小球藻复方型降血脂血压的保健品,该产品在血脂血压方面的效果显著由于市面上的保健单品,拥有较好的保健价值,在市场上具有广阔的开发前景。
发明内容
本发明的目的主提供一种配比简单,组方搭配合理,具有显著调节糖脂代谢紊乱、增强机体的免疫力等功效的的灵芝小球藻复方保健食品。
为了实现上述目的,本发明采用如下技术方案:
一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法,根据中医的“君臣佐使”理论和现代营养学知识,将灵芝子实体原料采用磨粉、热水浸提、过滤、减压浓缩干燥得到灵芝提取物粉末,再用小球藻,山药,西洋参,枸杞子,绞股蓝为原料制备复方浓缩液,再以灵芝提取物粉末和复方浓缩液制备具有辅助降血脂的灵芝小球藻复方保健食品。其主要原料配方按重量份数计包括:灵芝粉15-30份,小球藻粉5-10份,山药10-20份,西洋参3-6份,枸杞子10-20份,绞股蓝10-20份。
所述的一种辅助降血脂的灵芝小球藻复方保健食品的制备方法,具体包括如下步骤:
(1)灵芝提取物粉末的制备:
A.将灵芝子实体磨成细粉待用;
B.取步骤A得到的灵芝粉15-30份,加入10-20倍重量的蒸馏水,于80-100℃提取罐中提取1-3h,经过滤得灵芝水提取液和滤渣;将滤渣重复提取1-3次,合并提取液;
C、将合并后的提取液置于陶瓷膜过滤器中过滤处理,再于40-80℃、0.05-0.095MPa条件下浓缩,得浓缩液,经干燥得灵芝提取物粉末;
(2)复方浓缩液的制备 :
按原料配比取小球藻粉5-10份,山药10-20份,西洋参3-6份,枸杞子10-20份,绞股蓝10-20份于砂锅中用水浸过药材表面2-3cm,浸泡 10-20min,煮沸后文火煎煮 20-40min,冷却至室温,用纱布过滤,滤液经2500-4500r/min 离心并浓缩至 150-300mL,得复方浓缩液;
(3)灵芝小球藻复方保健食品的制备
用所述方法制备的灵芝提取物粉末和复方原浓缩液制备如口服液,胶囊,片剂,冲剂,固体饮料等不同剂型的营养、功能性食品。
对本发明的组方原理作详细说明 :
灵芝:灵芝又称林中灵、琼珍,是多孔菌科真菌灵芝的子实体。具有补气安神、止咳平喘、延年益寿。尤其是灵芝三萜等小分子活性物质的降血脂血压的功效非常显著。
小球藻:小球藻属绿藻纲,小球藻科,是一种优质的绿色营养源食品,具有高蛋白、低脂肪、低糖、低热量以及维生素、矿物质元素含量丰富的优点,并且具有降血脂降血压,抗氧化,解毒,抗肿瘤增强免疫力等保健功能。
山药:山药具有滋养强壮,助消化,敛虚汗,止泻之功效。其最适宜与灵芝搭配服用,具有防治糖尿病的作用。
西洋参:西洋参是五加科人参属多年生草木植物,别名花旗参、洋参等,其主要成分为人参皂苷,可以有效增强中枢神经,达到静心凝神、消除疲劳、增强记忆力等作用。常服西洋参可以抗心律失常、抗心肌缺血、抗心肌氧化、强化心肌收缩能力,养胃生津,降血脂等诸多功效。
枸杞子:枸杞子富含枸杞多糖,枸杞多糖是一种水溶性多糖具有生理活性,能够增强免疫功能,提高抗病能力,抑制肿瘤生长和细胞突变,降血脂血压,美容养颜等一系列功效。
绞股蓝:绞股蓝又称天堂草,是葫芦科、绞股蓝属草质攀援植物。用绞股蓝与灵芝搭配煮水或泡茶喝,可治疗高血压、高血脂、高血糖,脂肪肝等症。且有保肝解毒、辅助降血脂血糖的功效。
本发明的有益之处:
1.本发明全部采用天然物质为原料,可以直接辅助降血脂。
2.本发明配伍科学,安全可靠,适于工业化生产。
3.本发明为一种辅助降血脂的灵芝小球藻复方保健品,该产品在调节血脂方面的效果显著由于市面上的保健单品,拥有较好的保健价值,在市场上具有广阔的开发前景。
附图说明
图1为灵芝、小球藻复方保健品对高脂饮食诱导肥胖大鼠的血清总胆固醇的影响作用;
图2为灵芝、小球藻复方保健品对高脂饮食诱导肥胖大鼠的甘油三酯的影响作用;
图3灵芝、小球藻为复方保健品对高脂饮食诱导肥胖大鼠的高密度脂蛋白的影响作用;
图4灵芝、小球藻为复方保健品对高脂饮食诱导肥胖大鼠的低密度脂蛋白的影响作用。
具体实施方式
为了使本发明所述的内容更加便于理解,下面结合具体实施方式对本发明所述的技术方案做进一步的说明,但是本发明不仅限于此。
实施案例一:
一种辅助降血脂的灵芝小球藻复方保健口服液的制备方法的步骤为:
1、灵芝提取物粉末的制备:
A.将灵芝子实体磨成细粉待用;
B.取步骤A得到的灵芝粉15份,加入10倍重量的蒸馏水,于80℃提取罐中提取1h,经过滤得灵芝水提取液和滤渣;将滤渣重复提取1次,合并提取液;
C、将合并后的提取液置于陶瓷膜过滤器中过滤处理,再于40℃、0.05MPa条件下浓缩,得浓缩液,经干燥得灵芝提取物粉末。
2、复方浓缩液的制备 :
按原料配比取小球藻粉5份,山药10份,西洋参3份,枸杞子10份,绞股蓝10份于砂锅中用水浸过药材表面 2cm,浸泡 10min,煮沸后文火煎煮 20min,冷却至室温,用纱布过滤,滤液经2500r/min 离心并浓缩至 150mL,得复方浓缩液。
3、灵芝小球藻复方保健口服液的制备 :
A、将灵芝提取物粉末与复方浓缩液混合得到初始保健浓缩液 ;
B、将初始保健浓缩液煮沸,离心去除其中的不溶物质后,按重量比加入阿斯巴甜200ppm 和苹果酸 0.1%;
C、调配好的口服液趁热用盐水瓶灌装、锁盖,经水浴杀菌并检验合格后即成为产品。
实施案例二:
一种辅助降血脂的灵芝小球藻复方保健口服液的制备方法的步骤为:
1、灵芝提取物粉末的制备:
A.将灵芝子实体磨成细粉待用;
B.取步骤A得到的灵芝粉30份,加入20倍重量的蒸馏水,于100℃提取罐中提取3h,经过滤得灵芝水提取液和滤渣;将滤渣重复提取3次,合并提取液;
C、将合并后的提取液置于陶瓷膜过滤器中过滤处理,再于80℃、0.095MPa条件下浓缩,得浓缩液,经干燥得灵芝提取物粉末。
2、复方浓缩液的制备 :
按原料配比取小球藻粉10份,山药20份,西洋参6份,枸杞子20份,绞股蓝20份于砂锅中用水浸过药材表面3cm,浸泡20min,煮沸后文火煎煮40min,冷却至室温,用纱布过滤,滤液经4500r/min 离心并浓缩至300mL,得复方浓缩液。
3、灵芝小球藻复方保健口服液的制备 :
A、将灵芝提取物粉末与复方浓缩液混合得到初始保健浓缩液 ;
B、将初始保健浓缩液煮沸,离心去除其中的不溶物质后,按重量比加入阿斯巴甜500ppm和苹果酸0.5%;
C、调配好的口服液趁热用盐水瓶灌装、锁盖,经水浴杀菌并检验合格后即成为产品。
实施案例三:
一种辅助降血脂的灵芝小球藻复方保健口服液的制备方法的步骤为:
1、灵芝提取物粉末的制备:
A.将灵芝子实体磨成细粉待用;
B.取步骤A得到的灵芝粉20份,加入15倍重量的蒸馏水,于90℃提取罐中提取2h,经过滤得灵芝水提取液和滤渣;将滤渣重复提取2次,合并提取液;
C、将合并后的提取液置于陶瓷膜过滤器中过滤处理,再于60℃、0.07MPa条件下浓缩,得浓缩液,经干燥得灵芝提取物粉末。
2、复方浓缩液的制备 :
按原料配比取小球藻粉8份,山药15份,西洋参5份,枸杞子15份,绞股蓝15份于砂锅中用水浸过药材表面3cm,浸泡15min,煮沸后文火煎煮30min,冷却至室温,用纱布过滤,滤液经4000r/min 离心并浓缩至200mL,得复方浓缩液。
3、灵芝小球藻复方保健口服液的制备 :
A、将灵芝提取物粉末与复方浓缩液混合得到初始保健浓缩液 ;
B、将初始保健浓缩液煮沸,离心去除其中的不溶物质后,按重量比加入阿斯巴甜300ppm和苹果酸0.3%;
C、调配好的口服液趁热用盐水瓶灌装、锁盖,经水浴杀菌并检验合格后即成为产品。
动物实验
实验方法:
以符合现代人类生活方式(动物性食物为主的高脂饮食习惯)的角度出发,采用高糖高脂饲料(基础饲料67%,猪油10%,蔗糖20%,胆固醇3%)建立高脂饮食诱导的糖脂代谢紊乱模型,进行为期2个月的膳食干预喂养试验。实验设6组,包括正常对照组(NFD)、高脂对照组(HFD)和复方组(CP)。给予受试样品60天后,麻醉已禁食Wistar大鼠,在洁净工作台中,先通过心尖取血,将血液收集在采血管中,通过自动生化分析仪及试剂盒分析血清中总胆固醇(TC)、甘油三脂(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C等水平。
实验结果如图1-图4所示,经灵芝、小球藻复方保健品实验组(CPL、CPH)灌胃的高脂饮食诱导肥胖大鼠的血液指标与空白组与模型组相比均有变化,其中能够显著的降低血清中总胆固醇(TC)、甘油三脂(TG)以及低密度脂蛋白胆固醇(LDL-C)的水平,使高密度脂蛋白胆固醇(HDL-C)的水平有所升高。
附录:灵芝、小球藻复方保健品对高脂饮食诱导肥胖大鼠血液指标的影响
注:“NFD”指的是空白组,灌胃生理盐水,喂正常饲料;
“HFD”指的是模型组,灌胃生理盐水;喂高脂饲料;
“CPL”是指用复方低剂量灌胃的实验组,喂高脂饲料;
“CPH”指用复方高剂量灌胃的实验组,喂高脂饲料;
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
Claims (3)
1.一种辅助降血脂的灵芝小球藻复方保健食品,其特征在于:所述灵芝小球藻复方保健食品的主要原料按重量份数计包括:灵芝粉15-30份,小球藻粉5-10份,山药10-20份,西洋参3-6份,枸杞子10-20份,绞股蓝10-20份。
2.一种如权利要求书1所述的辅助降血脂的灵芝小球藻复方保健食品的制备方法,其特征在于:将灵芝子实体采用磨粉、热水浸提、过滤、减压浓缩干燥得到灵芝提取物粉末,再用小球藻,山药,西洋参,枸杞子,绞股蓝为原料制备复方浓缩液,再以灵芝提取物粉末和复方浓缩液制备具有辅助降血脂的灵芝小球藻复方保健食品。
3.根据权利要求书2所述的一种辅助降血脂的灵芝小球藻复方保健食品的制备方法,其特征在于:具体制备方法如下:
(1)灵芝提取物粉末的制备:
A.将灵芝子实体磨成细粉待用;
B.取步骤A得到的灵芝粉15-30份,加入10-20倍重量的蒸馏水,于80-100℃提取罐中提取1-3h,经过滤得灵芝水提取液和滤渣;将滤渣重复提取1-3次,合并提取液;
C、将合并后的提取液置于陶瓷膜过滤器中过滤处理,再于40-80℃、0.05-0.095MPa条件下浓缩,得浓缩液,经干燥得灵芝提取物粉末;
(2)复方浓缩液的制备 :
按原料配比取小球藻粉5-10份,山药10-20份,西洋参3-6份,枸杞子10-20份,绞股蓝10-20份于砂锅中用水浸过药材表面2-3cm,浸泡 10-20min,煮沸后文火煎煮 20-40min,冷却至室温,用纱布过滤,滤液经2500-4500r/min 离心并浓缩至 150-300mL,得复方浓缩液;
(3)灵芝小球藻复方保健食品的制备
将灵芝提取物粉末和复方浓缩液制备口服液,胶囊,片剂,冲剂,固体饮料,不同剂型的营养、功能性食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710152471.8A CN106942712A (zh) | 2017-03-15 | 2017-03-15 | 一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710152471.8A CN106942712A (zh) | 2017-03-15 | 2017-03-15 | 一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106942712A true CN106942712A (zh) | 2017-07-14 |
Family
ID=59467994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710152471.8A Pending CN106942712A (zh) | 2017-03-15 | 2017-03-15 | 一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106942712A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107581541A (zh) * | 2017-11-01 | 2018-01-16 | 佛山市三水区敏俊食品有限公司 | 一种保健食品的制备方法 |
CN114365844A (zh) * | 2022-01-28 | 2022-04-19 | 福建农林大学 | 一种调节肠道菌群、提高肠道免疫的竹荪复方保健食品及其制备方法 |
CN115590193A (zh) * | 2022-10-24 | 2023-01-13 | 厦门一三九生物科技有限公司(Cn) | 一种辅助降血糖血脂的小球藻复方保健食品及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101243882A (zh) * | 2008-03-27 | 2008-08-20 | 北京惠中铭捷生物科技有限公司 | 具有降血脂功能的保健食品及其制备方法 |
CN104042664A (zh) * | 2014-06-14 | 2014-09-17 | 桓仁满族自治县益仁堂中药材有限公司 | 一种降血脂颗粒 |
-
2017
- 2017-03-15 CN CN201710152471.8A patent/CN106942712A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101243882A (zh) * | 2008-03-27 | 2008-08-20 | 北京惠中铭捷生物科技有限公司 | 具有降血脂功能的保健食品及其制备方法 |
CN104042664A (zh) * | 2014-06-14 | 2014-09-17 | 桓仁满族自治县益仁堂中药材有限公司 | 一种降血脂颗粒 |
Non-Patent Citations (1)
Title |
---|
杨尔滨: "《营养素补充剂面面观》", 31 January 2007, 广西民族出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107581541A (zh) * | 2017-11-01 | 2018-01-16 | 佛山市三水区敏俊食品有限公司 | 一种保健食品的制备方法 |
CN114365844A (zh) * | 2022-01-28 | 2022-04-19 | 福建农林大学 | 一种调节肠道菌群、提高肠道免疫的竹荪复方保健食品及其制备方法 |
CN114365844B (zh) * | 2022-01-28 | 2024-05-28 | 福建农林大学 | 一种调节肠道菌群、提高肠道免疫的竹荪复方保健食品及其制备方法 |
CN115590193A (zh) * | 2022-10-24 | 2023-01-13 | 厦门一三九生物科技有限公司(Cn) | 一种辅助降血糖血脂的小球藻复方保健食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103749816B (zh) | 一种荷叶苦瓜降脂保健茶及其制作方法 | |
CN1840128A (zh) | 一种治疗心血管疾病的药物 | |
CN102422957B (zh) | 八味丹参茶及其制备工艺 | |
WO2021114586A1 (zh) | 一种具有提高免疫力功能的组合物及其制备方法和应用 | |
CN106942712A (zh) | 一种辅助降血脂的灵芝小球藻复方保健食品及其制备方法 | |
CN102366604A (zh) | 一种解酒中药制剂及制备方法 | |
CN102416101B (zh) | 治疗心力衰竭的中药组合物及其制备方法 | |
CN102846879B (zh) | 一种降血脂的组合物 | |
CN102134550B (zh) | 一种保健补酒及其制备工艺 | |
CN106943464A (zh) | 一种调节高血压的生物营养配方组合物 | |
CN102640826A (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN106106840A (zh) | 一种滋阴美容芝麻油的制备方法 | |
CN1288168C (zh) | 一种多糖类化合物制剂及制备方法 | |
CN101690770A (zh) | 能降血压、血脂,提高人体免疫机能的制剂及其制备方法 | |
CN106729498A (zh) | 一种放化疗后食用的蛋白粉及其制备方法 | |
CN106867826A (zh) | 一种沙棘酒及其制备方法 | |
CN105853610A (zh) | 一种增强免疫力及延缓衰老的功能性保健品及其制备方法 | |
CN103893627A (zh) | 具有保护和修复胃黏膜功能的组合物及其制备方法和应用 | |
CN102366458A (zh) | 一种治疗阴虚所致便秘的中药制剂及制备方法 | |
CN1183936C (zh) | 一种治疗高血压病的药物及其茶剂制备方法 | |
CN106072099A (zh) | 一种含青梅的辅助降血脂的保健食品及其制备方法 | |
CN105561179A (zh) | 防治三高血症的冲剂利脉饮及其制备方法 | |
CN110013497A (zh) | 一种可提高免疫力的中药软胶囊制备工艺 | |
CN108651629A (zh) | 一种石斛速溶食品 | |
CN109965278A (zh) | 一种养生营养粉 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170714 |